Page last updated: 2024-12-08

pentacarboxylic porphyrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pentacarboxylic porphyrin: RN given refers to 3-carboxymethyl 8,13,17-trimethyl cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID168756
MeSH IDM0105924

Synonyms (15)

Synonym
pentacarboxylic porphyrin
28100-78-9
21h,23h-porphine-2,7,12,18-tetrapropanoic acid, 3-(carboxymethyl)-8,13,17-trimethyl-
YDYIPLSPVWGSRD-TXUIXYGZSA-N
pentacarboxylporphyrin i
pentacarboxyporphyrin i
3-(carboxymethyl)-8,13,17-trimethyl-2,7,12,18-porphinetetrapropionic acid
3-(carboxymethyl)-8,13,17-trimethyl-2,7,12,18-porphinetetrapropionate
21h,23h-porphinepentacarboxylate
pentacarboxylic acid porphyrin i
21h,23h-porphinepentacarboxylic acid
3,3',3'',3'''-[3-(carboxymethyl)-8,13,17-trimethylporphyrin-2,7,12,18-tetrayl]tetrapropanoic acid
DTXSID40865413
3-(carboxymethyl)-8,13,17-trimethyl-21h,23h-porphine-2,7,12,18-tetrapropanoic acid
DTXSID001130804
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
Hemesynthesis defects and porphyrias018

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (55.56)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.32 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]